Abstract
INTRODUCTION
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease characterized by a dysregulated mucosal immune response [1] . Many cytokines are involved in the immunopathogenesis of UC, but the importance of cytokine signaling in UC is not fully understood.
The suppressors of cytokine signaling (SOCS) are a family of proteins that regulates the strength and duration of the cytokine signaling cascade. There are eight members of the SOCS protein family: the cytokineinducible SH2 domain-containing protein (CIS) and SOCS1 through SOCS7 [2] [3] [4] [5] [6] [7] . Accumulated evidence shows that SOCS proteins can potently block the Jak/STAT pathway in the pathogenesis of various inflammatory diseases [8] . The functions of SOCS1 and SOCS3 have been well documented in mouse colitis models. In a dextran sulfate-induced mouse model of colitis, SOCS3 expression was increased at day 5 and remained high for 2 wk [9] . Transgenic mice expressing a dominant-negative mutant of SOCS3 showed increased phosphorylation of STAT3 and suffered a more severe colitis than did wild-type control mice [9] . In a 2, 4, 6-Trinitrobenzene sulphonic acid-induced mouse model of colitis, SOCS1 expression was induced in intestinal mucosal lymphocytes, and SOCS1 transgenic mice developed colitis spontaneously with age [10] . It has been already reported that both SOCS1 and SOCS3 are expressed at high levels in the infl amed colonic mucosa of humans with UC [9, 10] , but functional significance of local SOCS expression remains unclear. The present study was undertaken to investigate the relation between levels of SOCS mRNAs and degree of infl ammation in the colonic mucosa of UC patients.
MATERIALS AND METHODS

Subjects
Our subjects were 62 patients with UC who underwent colonoscopy. The age of the patients ranged from 13 to 76 years (mean + SD, 38.6 + 13.3 years). Rectal lesions were classified macroscopically with endoscopic Matts' classifi cation (Table 1 ) [11] . Patient characteristics are shown in Table 2 .
After endoscopic obser vation by colonoscopy (450ZH; Fuji Photo Optical Co., Ltd, Saitama, Japan, and/or 240Q; Olympus Co., Ltd, Tokyo, Japan), biopsy specimens were obtained endoscopically from these patients for histologic analysis and reverse transcriptionpolymerase chain reaction (RT-PCR) assay. The biopsy specimens were fi xed routinely in 10% buffered formalin, stained with hematoxylin and eosin, and diagnosed histologically according to histologic Matts' classifi cation (Table 1 ) [11] .
Oligonucleotides
For the amplification of SOCS1, a pair of PCR primers was synthesized. The sequences were 5' -CCTTCCCCTTCCAGATTTGA-3' for the 5' primer and 5' -TCCTGGCTCCAGATACAGTT-3' for the 3' primer. For the amplification of SOCS3, the sequences of the primers were 5'-TCACCCACAGCAAGTTTCCCGC-3' for the 5' primer and 5'-GTTGACGGTCTTCCGACAGAGATGC-3' for the 3' primer. For the amplification of GAPDH, the sequences were 5'-AACATCATCCCTGCCTCTAC-3' for the 5' primer and 5'-TGGCAGGTTTTTCTAGACGG-3' for the 3' primer.
Semi-quantitative RT-PCR
Total RNA from biopsy specimens was isolated with an Rneasy Mini kit (Qiagen, Valencia, CA, USA). Firststrand cDNA was synthesized from 1 μg of total RNA with random 9-mers in a 20-μL total reaction volume. Before cDNA symthesis, the RNA sample was treated with Rnase-Free Dnase (Qiagen) to eliminate possible false positives due to residual genomic DNA. PCR was performed in triplicate in 10 μL reactions. GAPDH was used as an internal control for effi ciency of RT and amount of RNA. Amplification conditions consisted of denaturation for 4 min at 94℃, annealing for 1 min at 65℃, and a fi nal extension for 7 min at 72℃. The samples were amplifi ed for 35 cycles. PCR products were run on 2% 
RESULTS
Expression of SOCS3 mRNA in the colonic mucosa in patients with UC SOCS3 mRNA was detected in the colonic mucosa of patients with UC ( Figure 1A ), consistent with previous reports [12] . Upper level shows 4 cases of endoscopic Matts 1, and lower level shows 4 cases of Matts 3 and 4. Cases 1 to 4 with Matts 1 had low expression of SOCS3, and cases 5 to 8 with Matts 3 and 4 had high levels of SOCS3, as compared to expression of GAPDH. Quantitative analysis revealed that expression of SOCS3 mRNA was signifi cantly higher in infl amed mucosa of UC than in inactive mucosa ( Figure 2A ). SOCS3 mRNA levels was also signifi cantly correlated with histological Matts' grade ( Figure 2B ).
Expression of SOCS1 mRNA in colonic mucosa in patients with UC SOCS1 mRNA was expressed in both inflamed and uninflamed UC mucosa ( Figure 1B) ; however, the level did not differ significantly ( Figure 3A ). The SOCS1 mRNA expression was all equally expressed compared to GAPDH. Quantitative analysis showed that there was no correlation between SOCS1 mRNA expression in the colonic mucosa and histologic Matts' grade ( Figure 3B ).
Relation between SOCS1 and SOCS3 mRNA expression in patients with UC Although SOCS1 and SOCS3 are regulated by many cytokines, the relation between SOCS1 and SOCS3 remains un- clear. Therefore, we evaluated the relation between expression of SOCS3 and SOCS1 mRNA and found that there was no correlation between SOCS1 and SOCS3 mRNA expression in each colonic biopsy specimen ( Figure 4 ).
Relation between expression of SOCS mRNAs and steroid use
Because treatment with steroids is known to influence several immunological responses, we investigated the effect of steroid use on SOCS expression. There was a tendency for expression of both SOCS1 and SOCS3 to decrease in response to steroid treatment, but this difference was not statistically signifi cant ( Figure 5 ).
Relation between clinical activity of UC and the level of SOCS
We examined the relation between the clinical activity and expression of SOCS mRNAs. The clinical activity of UC was evaluated according to the clinical activity index (CAI), which is calculated as the sum of each parameter [13] . We found that SOCS3 mRNA expression correlated well with CAI, whereas there was no correlation between SOCS1 mRNA and CAI ( Figure 6 ).
Expression of SOCS mRNAs in predicting relapse of UC
To determine if evaluation of SOCS expression is useful for prediction of prognosis for UC, we checked SOCS mRNA levels and CAI over a 12-mo period. Eighteen patients with UC in remission (CAI = 1 or 2) were analyzed for rectal SOCS expression and followed up. The patients were assessed when relapse occurred during the 12-mo period. A relapse was defined as CAI > 2. No change in treatment was made during the study. These patients were classified into two groups, low and high, according to SOCS expression levels. High SOCS3 was a SOCS3-to-GAPDH ratio of > 0.3, whereas low SOCS3 was a SOCS3-to-GAPDH ratio of ≤ 0.3. High SOCS1 was a SOCS1-to-GAPDH ratio of > 0.6, and low SOCS1 was a SOCS1-to-GAPDH ratio of ≤ 0.6. Patients who had low levels of SOCS3 (n = 14) remained in remission for the12-mo period, whereas patients with high levels of SOCS3 (n = 4) had low rate of maintaining an existing remission over the 12-mo period (Figure 7 ). There was no correlation between SOCS1 level and remission rate. No differences were found between the high and low SOCS3 groups in Figure 1 Expression of SOCS3 (A) and SOCS1 (B) mRNA in the colonic mucosa with UC. PCR was performed in triplicate for each sample. GAPDH was included as an internal control for efficiency of RT and amount of RNA. The colonic mucosae in cases 1 to 4 were shown endoscopically to be in remission and those in cases 5 to 8 were shown endoscopically to be active. 
DISCUSSION
In the present study, we found that expression of SOCS3 mRNA is increased according to the degree of mucosal infl ammation in UC and that the level of SOCS3 may be a useful prognostic marker for patients with UC. These fi ndings suggest that SOCS3 has a signifi cant role in UC.
In this study, we found a close correlation between SOCS3 expression and the severity of both macroscopic and histologic inflammation of UC. In contrast, SOCS1 expression did not correlate with the severity of colonic inflammation. Expression of both SOCS1 and SOCS3 is induced by a wide variety of inflammatory and antiinflammatory cytokines, including IL-6, IL-12, IFN-γ, and IL-10 [8] . We also found that there was no correlation between the levels of SOCS1 and SOCS3. Thus, high expression of SOCS3 may not be a secondary effect of mucosal cytokine induction due to inflammatory responses.
The pathogenesis of UC is still unknown, but there 
is accumulating evidence that T-helper 2 (T H 2)-skewing immune dysregulation may be crucial in UC. Fuss et al [14] reported that lamina propria lymphocytes from UC secrete large amounts of IL-5 compared to those from healthy controls and Crohn's disease patients. Recently, it was reported that lamina propria mononuclear cells from patients with UC produce large amounts of IL-13, much more than those from control subjects or patients with Crohn's disease [15] . Moreover, it was also reported that IL-13 is the key effector T H 2 cytokine in UC that affects epithelial tight junctions, apoptosis, and cell restitution [16] . Taken together, these data all suggest that the T H 2-type immune response plays a crucial role in the pathogenesis of UC.
SOCS3 is expressed predominantly by T H 2 cells [17] . SOCS3 negatively regulates the IL-12 to STAT4 Th1 pathways and is possibly required for mediating T H 2 responses [18] . Interestingly, Seki et al [19] described a strong correlation between SOCS3 expression and the pathology of asthma and atopic dermatitis, well-known T H 2-type diseases, as well as serum IgE levels in allergic human patients. They also showed that SOCS3 transgenic mice have increased T H 2 responses in an airway hyperresponsibility model system [19] . Thus, SOCS3 has an important role in regulating the onset and maintenance of T H 2-mediated immune diseases. Recently, it was reported that overexpression of SOCS3 in lung through adenovirus SOCS3 gene transfer enhances IgG immune complex-induced lung injury [20] . SOCS3 expressed at high levels in infl amed mucosa may therefore have a pathologic role in UC.
We have not examined the cellular localization of mucosal SOCS3 expression. In mice, it has been confi rmed that SOCS3 mRNA is expressed mainly in hyperplastic epithelial cells and lamina propria mononuclear cells in DSS-treated inflamed colon [9] . Han et al [21] confirmed that SOCS3 protein is increased and localized primarily in lamina propria lymphocytes with a lower level of expression in crypt epithelial cells in a mouse model of colitis. According to our data, expression of SOCS3 mRNA is well correlated with the degree of histologic inflammation. Therefore, accumulation of inflammatory lamina propria immune cells may be one of the main sources of increased SOCS3 mRNA. The correlation between SOCS3 expression and the severity of UC raises the possibility that high SOCS3 expression in patients may be attributable to the accumulation of T H 2 cells in the lamina propria, resulting in exacerbation of mucosal Figure 6 Relation between expression of SOCS mRNAs and CAI. SOCS3 expression is well correlated with CAI. There was no correlation between SOCS1 expression and CAI. NS: not signifi cant. inflammation. Further studies of the cellular localization of SOCS3 are needed.
To explore the impact of high expression of SOCS3, we examined the relation between the period of remission and SOCS3 expression. The rate of remission maintenance was significantly higher in the low SOCS3 group than in the high SOCS3 group for 1 year. This finding also suggests that mucosal SOCS3 expression is not merely the result of infl ammatory change. SOCS3 may be involved in the progression of the infl ammation in UC.
Treatment with steroids is known to affect cellular immune responses. We found that the patients treated with steroids showed lower levels of both SOCS1 and SOCS3 than did untreated patients. It has been reported that rat SOCS3 gene in hepatocytes is down-regulated by glucocorticoids [22] . In contrast, removal of adrenal steroids by adrenalectomy reduces SOCS3 mRNA and protein levels [23] . It has been reported that SOCS1 is involved in the response of leukemia cells to glucocorticoids [24] . These raise the possibility that steroids may directly regulate SOCS expression. Targeting SOCS3 may provide a novel strategy to UC.
In summary, our present observations suggest that mucosal SOCS3 expression may play a critical role in the development of colonic infl ammation associated with UC. Monitoring of rectal SOCS3 expression may be a useful means to evaluate prognosis of patients with UC.
